Clinical Trials Sponsored by Uganda Heart Institute

Total 4887 results

Children's Hospital Medical Center, Cincinnati
Uganda Heart Institute

Recruiting

Accelerating Delivery of rheUmatic Heart Disease Preventive iNterventions in Northern Uganda (ADUNU)

Rheumatic Heart Disease

Uganda
Children's Hospital Medical Center, Cincinnati
Uganda Heart Institute

Recruiting

GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial

Rheumatic Heart Disease

Uganda
Children's Hospital Medical Center, Cincinnati
Uganda Heart Institute

Completed

Train the Trainer Curriculum to Scale up AI Supported Echo for RHD Screening in a Public Health System (ADD-RHD 2B)

Rheumatic Heart Disease

Uganda
Children's Hospital Medical Center, Cincinnati
Uganda Heart Institute

Completed

Case Management and Peer Support Groups for Prophylaxis Adherence in Rheumatic Heart Disease (CAMPS)

Rheumatic Heart Disease

Uganda
Infectious Diseases Research Collaboration, Uganda
London School of Hygiene and Tropical Medicine; Makerere University; Ministry... and other collaborators

Active, not recruiting

Leveraging the HIV Platform for Hypertension Control in Uganda (INTEGRATED HIV/HTN) STUDY

Hypertension | HIV

Uganda
Children's Hospital Medical Center, Cincinnati
Children's National Research Institute; Uganda Heart Institute

Active, not recruiting

Rheumatic Heart Disease Community Streptococcal Treatment Program "RESET"

Rheumatic Heart Disease

Uganda
RAND
Infectious Diseases Institute, Uganda

Completed

Pilot Intervention to Empower HIV Clients as Prevention Advocates in Uganda

HIV

Uganda
Infectious Diseases Research Collaboration, Uganda
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Integration of Hypertension Management in HIV Care in Uganda (PULESAUganda)

Hypertension | HIV/AIDS

Uganda
Children's Hospital Medical Center, Cincinnati
Uganda Heart Institute; Murdoch Children's Research Institute, Melbourne Australia

Active, not recruiting

A Long-term Follow up Study for Patients Who Participated in the GOAL Trial (GOAL-Post)

Rheumatic Heart Disease

Uganda
Makerere University
Infectious Diseases Institute, Uganda

Completed

Call for Life Youth ART Adherence Study (C4L-Youth)

mHealth | HIV-1-infection | ART Adherence

Uganda
Makerere University
Infectious Diseases Institute, Uganda

Unknown

Nucleosides And Darunavir/Dolutegravir In Africa (NADIA)

Human Immunodeficiency Virus

Uganda
Makerere University
Infectious Diseases Institute, Uganda

Unknown

Syphilis Treatment of Partners Trial (STOP)

Syphilis Infection

Uganda
Washington University School of Medicine
National Cancer Institute (NCI); Uganda Cancer Institute; Reach the Youth Uganda

Withdrawn

Suubi4Cancer: Improving Access to Pediatric Cancer Services and Treatment Adherence Among Children Living With HIV/AIDS

Cancer | HIV/AIDS

Uganda
Duke University
Makerere University; Uganda Cancer Institute

Not yet recruiting

KeyScope Study in Uganda

Abdominal Neoplasm

Uganda
National Human Genome Research Institute (NHGRI)
University of Lagos, Nigeria; Uganda Heart Institute

Completed

The Genetic Basis of Congenital Heart Disease in Africa

Heart Disease | Congenital Heart Disease

United States, Nigeria, Thailand
University of British Columbia
Uganda Cancer Institute

Completed

Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge) (ASPIRE)

Cervical Cancer | Papillomavirus Infections | Pre-Cancerous Dysplasia | Human Papillomavirus 16 | Human Papillomavirus 18

Uganda
Centers for Disease Control and Prevention
MRC/UVRI and LSHTM Uganda Research Unit; Ministry of Health, Uganda; Infectious...

Unknown

Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old

Yellow Fever
Massachusetts General Hospital
National Institutes of Health (NIH); Infectious Diseases Institute, Uganda

Completed

Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma

Kaposi Sarcoma

Uganda
RAND
Indiana University; Makerere University; Infectious Diseases Institute, Uganda

Active, not recruiting

Randomized Controlled Trial of Game Changers

HIV Prevention

Uganda
Fred Hutchinson Cancer Center
Makerere University; Uganda Cancer Institute

Completed

Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda

HIV/AIDS and Infections

Uganda
RemovAid AS
Karolinska Institutet; FHI 360; Mulago Hospital, Uganda

Completed

Safe Access: Trial With RemovAid Device

Removal of a Contraceptive Subdermal Implant

Uganda
Minneapolis Heart Institute Foundation
Minneapolis Heart Institute; Twin Cities Heart Foundation

Terminated

Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis (RADAR)

Aortic Valve Stenosis

United States
Makerere University
University of Cape Town; Uganda Cancer Institute

Unknown

Detecting and Treating Subclinical Anthracycline Therapy Related Cardiac Dysfunction in Low Income Country. (SATRACD)

Chemotherapy Related Cardiac Dysfunction
Makerere University
MRC/UVRI and LSHTM Uganda Research Unit; Ministry of Health, Uganda; Epicentre; Makerere University Lung Institute and other collaborators

Not yet recruiting

Solidarity/Tokomeza Ebola Trial (TOKOMEZA)

Sudan Ebola Virus Vaccines
Yale University
University Health Network, Toronto; Fogarty International Center of the National... and other collaborators

Completed

mHealth for Self-care of Heart Failure in Uganda

Heart Failure

Uganda
Montreal Heart Institute
Ottawa Heart Institute Research Corporation

Completed

LVEF Prediction During ACS Using AI Algorithm Applied on Coronary Angiogram Videos (CathEF)

Acute Coronary Syndrome | Left Ventricular Dysfunction

Canada
InCor Heart Institute

Recruiting

Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:

Coronary Artery Disease | Menopause

Brazil
Montreal Heart Institute

Not yet recruiting

Multidisciplinary Approach for High-risk Patients Leading to Early Diagnosis of Canadians With Heart Failure (MAPLE-CHF)

Heart Failure

Canada
InCor Heart Institute

Recruiting

The Effects of Resveratrol on Sirtuins and Apoptosis Biomarkers (RE-AGES)

Coronary Artery Disease | Menopause | Endothelial Dysfunction

Brazil
Montreal Heart Institute

Recruiting

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes (COLCOT-T2D)

Cardiovascular Diseases | Diabete Type 2

Canada
Montreal Heart Institute

Recruiting

Home-based Heat Therapy for Type 2 Diabetes

Diabetes Mellitus, Type 2 | Heat Exposure

Canada
German Heart Institute

Recruiting

Validation of a Non-invasive Assessment of Central Venous Oxygen Saturation by Using MRI

Heart Failure

Germany
Montreal Heart Institute

Recruiting

Impact of FDG-PET/CT on Management of Patients With Native Valve Infective Endocarditis (PET-NAVIE)

Infective Endocarditis | Native Valve Endocarditis

Canada
InCor Heart Institute

Recruiting

PREemptive Analgesia With preGABAlin in HEART Surgery (PREGABA-HEART)

Postoperative Pain

Brazil
Montreal Heart Institute

Enrolling by invitation

Cardiac Rehabilitation in Congenital Heart Disease: Effects on Brain and Cognitive Functions (CongeNIRS)

Congenital Heart Disease | Congenital Heart Defects

Canada
Montreal Heart Institute

Completed

Feasibility of Prediabetes Remission in Adults With Coronary Heart Disease (DIABEPIC1)

Prediabetic State | Coronary Heart Disease | Healthy Lifestyle | Remission

Canada
Montreal Heart Institute

Completed

Sauna Bathing to Improve Vascular Health of Adults With Heart Disease

Coronary Artery Disease

Canada
Tabba Heart Institute

Completed

Combination of InnoSEAL Plus TR Band Compared to TR Band Alone

Hematoma | Radial Artery Occlusion

Pakistan
Montreal Heart Institute

Completed

Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation (AFFORD)

Atrial Fibrillation

Canada
German Heart Institute

Unknown

Effect of Prescribed Cardiac Rehabilitation in Patients With Advanced Heart Failure or Ventricular Assist Device

Heart Failure

Germany
Tabba Heart Institute

Unknown

Radiation Dose Reduction Using Advanced Fluoroscopy Options in Coronary Cath Lab

Coronary Artery Disease | Radiation Exposure

Pakistan
Montreal Heart Institute

Withdrawn

Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF (EVOLVE-HF)

Heart Failure | Functional Mitral Regurgitation
Montreal Heart Institute

Completed

Effect of Exercise Training on Left Ventricular Function in Patients Post Myocardial Infarction (EXIT-V)

Myocardial Infarction | Coronary Artery Disease | Heart Failure

Canada
Montreal Heart Institute

Completed

Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy (NOVA-SKIN)

Chronic Stable Angina

Canada
Montreal Heart Institute

Completed

Evaluation of the E/e' Ratio of the Mitral Annulus in Predicting Fluid Responsiveness.

Left Ventricular Function Diastolic Dysfunction | Fluid Responsiveness

Canada
InCor Heart Institute

Unknown

Peripherally Inserted Central Catheter Use for Dobutamine Infusion in Heart Failure Patients (DOBUTAPICC)

Congestive Heart Failure

Brazil
Montreal Heart Institute

Completed

Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension (PB-02)

Pulmonary Hypertension

Canada
Montreal Heart Institute

Completed

Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary Circulation

Pulmonary Hypertension | Pulmonary Disease

Canada
InCor Heart Institute

Unknown

Renal Denervation in Patients With Heart Failure With Normal LV Ejection Fraction

Hypertension | Heart Failure, Diastolic

Brazil
Arizona Heart Institute

Unknown

Clinical Study of Abdominal Aortic Aneurysm Exclusion (TALENT Abdominal) (l)

Abdominal Aortic Aneurysm

United States

Clinical Trials Sponsored by Uganda Heart Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations